Outcome | Cohort | OR (95% CI) | P value |
Bleeding | Prasugrel versus clopidogrel | 0.732 (0.588 to 0.910) | 0.005 |
Ticagrelor versus clopidogrel | 0.648 (0.493 to 0.852) | 0.002 | |
Ticagrelor versus prasugrel | 0.866 (0.600 to 1.249) | 0.441 | |
MACE | Prasugrel versus clopidogrel | 0.940 (0.837 to 1.056) | 0.296 |
Ticagrelor versus clopidogrel | 1.171 (1.037 to 1.323) | 0.011 | |
Ticagrelor versus prasugrel | 1.249 (1.059 to 1.472) | 0.008 | |
30-Day mortality | Prasugrel versus clopidogrel | 0.870 (0.777 to 0.973) | 0.014 |
Ticagrelor versus clopidogrel | 1.074 (0.954 to 1.208) | 0.237 | |
Ticagrelor versus prasugrel | 1.216 (1.031 to 1.435) | 0.020 | |
1-Year mortality | Prasugrel versus clopidogrel | 0.891 (0.815 to 0.974) | 0.011 |
Ticagrelor versus clopidogrel | 1.058 (0.962 to 1.163) | 0.247 | |
Ticagrelor versus prasugrel | 1.188 (1.042 to 1.354) | 0.010 |
ORs, CIs (in brackets) and P values represent the pooled results over 10 multiple imputed dataset instances.
MACE, major adverse cardiovascular events.